Trinity Capital — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Neurolens, Inc.neurolens.cominDec 2023
Neurolens makes therapeutic eyeglass lenses with patented Contoured Prism technology and a measurement device that customizes prescriptions to reduce symptoms of eye misalignment such as headaches, neck pain, motion sickness, and eye strain.
HealthtechMedical Devices
Co-investorsFlying L Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.